Overall, our results indicated that anti-IL17 potently inhibited LPS-activated NFκB signaling in the lung tissue of ALI mice model, leading to significant suppression of inflammation and tissue injury. This evidence concerns the gene IL17A and acute respiratory distress syndrome.